Luo H - Search Results

1

Increased expression of OCT4 is associated with low differentiation and tumor recurrence in human hepatocellular carcinoma.

Dong Z, Zeng Q, Luo H, Zou J, Cao C, Liang J, Wu D, Liu L. Dong Z, et al. Among authors: luo h. Pathol Res Pract. 2012 Sep 15;208(9):527-33. doi: 10.1016/j.prp.2012.05.019. Epub 2012 Jul 21. Pathol Res Pract. 2012. PMID: 22824146

2

[Effect of protein kinase CK2 gene silencing on radiosensitization in human nasopharyngeal carcinoma cells].

Liu L, Zou JJ, Luo HS, Wu DH. Liu L, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2009 Aug;29(8):1551-3. Nan Fang Yi Ke Da Xue Xue Bao. 2009. PMID: 19726289 Chinese.

3

[Correlation of casein kinase 2β overexpression to the metastatic ability of colorectal cancer cells in vitro].

Zou JJ, Luo HS, Huang ZY, Dong ZY, Zeng Q, Wu DH. Zou JJ, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Apr;31(4):628-32. Nan Fang Yi Ke Da Xue Xue Bao. 2011. PMID: 21515457 Chinese.

4

Protein kinase CK2α is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes.

Zou J, Luo H, Zeng Q, Dong Z, Wu D, Liu L. Zou J, et al. Among authors: luo h. J Transl Med. 2011 Jun 25;9:97. doi: 10.1186/1479-5876-9-97. J Transl Med. 2011. PMID: 21702981 Free PMC article.

5

Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma.

Luo H, Zou J, Dong Z, Zeng Q, Wu D, Liu L. Luo H, et al. Biochem J. 2012 Mar 1;442(2):311-21. doi: 10.1042/BJ20111517. Biochem J. 2012. PMID: 22132820

6

Down-regulation of RhoE is associated with progression and poor prognosis in hepatocellular carcinoma.

Luo H, Dong Z, Zou J, Zeng Q, Wu D, Liu L. Luo H, et al. J Surg Oncol. 2012 Jun 1;105(7):699-704. doi: 10.1002/jso.23019. Epub 2011 Dec 28. J Surg Oncol. 2012. PMID: 22213123

7

Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.

Luo HS, Wu DH. Luo HS, et al. Pathol Res Pract. 2019 Mar;215(3):512-518. doi: 10.1016/j.prp.2019.01.009. Epub 2019 Jan 7. Pathol Res Pract. 2019. PMID: 30638952

8

Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study.

Bai X, Wu DH, Ma SC, Wang J, Tang XR, Kang S, Fu QJ, Cao CH, Luo HS, Chen YH, Zhu HB, Yan HH, Wu YL, Dong ZY. Bai X, et al. J Immunother Cancer. 2020 Jun;8(1):e000381. doi: 10.1136/jitc-2019-000381. J Immunother Cancer. 2020. PMID: 32606052 Free PMC article.

9

A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.

Luo HS, Huang SF, Xu HY, Li XY, Wu SX, Wu DH. Luo HS, et al. Radiat Oncol. 2020 Oct 29;15(1):249. doi: 10.1186/s13014-020-01692-3. Radiat Oncol. 2020. PMID: 33121507 Free PMC article.

10

HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort study.

Rong ZX, Wei W, Zeng Q, Cai XT, Wang YY, Wang J, Luo HS, Xiao LS, Lin JR, Bai X, Zhang YP, Han DD, Dong ZY, Wang W, Wu DH, Ma SC. Rong ZX, et al. BMC Med. 2024 Oct 8;22(1):443. doi: 10.1186/s12916-024-03676-6. BMC Med. 2024. PMID: 39380026 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,430 results

Search Page

Filters